Trial intelligence / Profile preview

SPF and UVA Protection Assay of Coppertone (BAY 987517)

NCT02717351Completed

Sponsor
Bayer
Start
Mar 2016
Primary completion
Mar 2016
Modality
Transdermal Patches, Hydrogel Systems, Small Molecules
Countries
1
01

Overview

Single-arm trial of BAY987517 in sunburn, sponsored by Bayer. Primary endpoints: Minimal Erythema Dose at 15 months and Minimal Persistent Pigment Darkening Dose at 15 months. Started Mar 2016; status: completed.

02

Drugs

BAY987517
03

Conditions

sunburn

Beyond the preview

Go deeper on NCT02717351.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02717351.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call